27 completed, 9 unknown, 6 recruiting, 3 terminated. 12 Phase 2, 10 Phase 3, 7 Phase 1, 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Completed 7, Terminated 2, Unknown 2, Recruiting 1 |
| Phase 3 | 10 | Completed 8, Unknown 2 |
| Phase 1 | 7 | Completed 6, Unknown 1 |
| Phase 4 | 2 | Unknown 2 |
| Not applicable | 1 | Completed 1 |
Follow Chemotherapy-Induced Neutropenia: new trials by email Literature Review of Chemotherapy-Induced Neutropenia trials Research Report on Chemotherapy-Induced Neutropenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Correlation Between ANC and Bone Pain in Breast Cancer Patients Receiving Long-Acting G-CSF Breast Cancer, Chemotherapy-Induced Neutropenia | Not yet recruiting | The First Affiliated Hospital with Nanjing Medical University | 132 | 2026-09-30 | 2026-09-08 | |
| G-CSF-Related Bone Pain and Supportive Care Strategies in Patients With Solid Tumors Filgrastim (G-CSF), Naproxen, Loratadine - Solid Tumors, Chemotherapy-induced Neutropenia | Completed | Ankara Etlik City Hospital | 190 | 2025-09-27 | 2026-10-09 | |
| Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries. Cancer, Cancer-related Problem/Condition | Recruiting | Pomeranian Medical University Szczecin | 265 | 2025-03-17 | 2026-02-27 | |
| Clinical Study on the Safety, Efficacy and Pharmacokinetics of Telpegfilgrastim in Pediatric Cancer Patients with Chemotherapy Telpegfilgrastim - Chemotherapy-Induced Neutropenia | Phase 2 | Recruiting | Sun Yat-sen University | 97 | 2024-12-01 | 2025-03-04 |
| Mecapegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Advanced Breast Cancer No Prophylactic G-CSF, Short-acting G-CSF, Long-acting G-CSF - Breast Cancer, Chemotherapy-induced Neutropenia | Recruiting | Zheng Yabing | 200 | 2024-10-24 | 2026-10-27 | |
| Breath Analysis for the Detection of Invasive Fungal Infections Secondary electrospray ionization high-resolution mass spectrometry (SESI-HRMS) - Leukemia, Leukemia, Myeloid | Recruiting | University of Zurich | 130 | 2024-08-19 | 2025-04-10 | |
| Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor Telpegfilgrastim Injection - Chemotherapy-induced Neutropenia | Recruiting | Anhui Provincial Hospital | 318 | 2024-08-15 | 2025-07-31 | |
| Danish Elder Lymphoma Patient Hematopoietic Investigation DNA repair gene mutation analysis - Lymphoma, Chemotherapy-induced Neutropenia | Recruiting | Copenhagen University Hospital, Rigshospitalet | 300 | 2022-01-01 | 2023-12-22 | |
| Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer. Everion®, CORE® - Pediatric Cancer, Febrile Neutropenia | Completed | Insel Gruppe AG, University Hospital Bern | 20 | 2021-09-16 | 2022-07-11 | |
| Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab Trilaciclib, Gemcitabine, Cisplatin - Urothelial Carcinoma, Bladder Cancer | Phase 2 | Terminated | G1 Therapeutics, Inc. | 92 | 2021-06-04 | 2025-09-08 |
| Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma Pegylated rhG-CSF, rhG-CSF - Chemotherapy-induced Neutropenia, Lymphoma | Phase 2 | Unknown | The First Hospital of Jilin University | 170 | 2020-12-20 | 2022-07-07 |
| Study to Evaluate the Usability of PointCheck PointCheck - Neoplasms, Chemotherapy-induced Neutropenia | Completed | Leuko Labs, Inc. | 94 | 2020-02-11 | 2023-08-22 | |
| Feasibility of Monitoring Health Data in Pediatric Patients Undergoing Chemotherapy Everion - Pediatric Cancer, Febrile Neutropenia | Completed | Insel Gruppe AG, University Hospital Bern | 20 | 2019-11-29 | 2021-07-08 | |
| Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia Pegfilgrastim, Plinabulin, D5W Placebo - Chemotherapy-induced Neutropenia | Phase 3 | Unknown | BeyondSpring Pharmaceuticals Inc. | 221 | 2019-10-23 | 2021-01-15 |
| Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer Long-acting granulocyte colony stimulating factor, Short-acting granulocyte colony stimulating factor - Chemotherapy-induced Neutropenia, Febrile Neutropenia, Drug-Induced | Phase 3 | Unknown | Lei Li | 200 | 2019-10-01 | 2019-10-08 |
| Real World Study of PEG-rhG-CSF in Prevention of Chemotherapy-induced Neutropenia PEG-rhG-CSF - Chemotherapy-induced Neutropenia, Myelosuppression | Unknown | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 1500 | 2019-02-13 | 2019-02-19 | |
| Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients Granulocyte Colony-Stimulating Factor - Granulocyte Colony-Stimulating Factor, Chemotherapy-induced Neutropenia | Phase 4 | Unknown | University of Mississippi Medical Center | 150 | 2019-02-01 | 2020-03-13 |
| G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients Long-acting G-CSF, Short-acting G-CSF - Gynecologic Cancer, Myelosuppression Adult | Phase 4 | Unknown | Lei Li | 100 | 2019-01-03 | 2019-01-07 |
| Efficacy, Safety and Cost-effectiveness of PEG-rhG-CSF for Primary vs Secondary Prophylaxis PEG-rhG-CSF - Chemotherapy-induced Neutropenia | Unknown | Anhui Provincial Hospital | 1000 | 2018-10-01 | 2018-10-10 | |
| Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3 Plinabulin, Pegfilgrastim, Saline Placebo - Chemotherapy-induced Neutropenia | Phase 3 | Completed | BeyondSpring Pharmaceuticals Inc. | 105 | 2018-05-29 | 2024-08-29 |
Showing 20 of 46. Sign in to see all of them.
Neutropenia (12) · Breast Neoplasms (11) · Neoplasms (10) · Febrile Neutropenia (8) · Chemotherapy-Induced Febrile Neutropenia (2) · Depression (2) · Fatigue (2) · Lymphoma (2) · Vomiting (2) · Anxiety Disorders (1) · Carcinoma, Ovarian Epithelial (1) · Carcinoma, Transitional Cell (1) · Colorectal Neoplasms (1) · Constipation (1) · Fever (1)
Hemic and Lymphatic Diseases (21) · Agranulocytosis (19) · Cytopenia (19) · Hematologic Diseases (19) · Leukocyte Disorders (19) · Leukopenia (19) · Neoplasms (18) · Neoplasms by Site (15) · Breast Diseases (11) · Skin Diseases (11) · Skin and Connective Tissue Diseases (11) · Neutropenia (7) · Neoplasms by Histologic Type (5) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (4)
pegfilgrastim (10) · Granulocyte Colony-Stimulating Factor (5) · Filgrastim (4) · NPI 2358 (4) · pegylated granulocyte colony-stimulating factor (4) · Docetaxel (3) · Doxorubicin (3) · Cyclophosphamide (2) · Drug Therapy (2) · balugrastim (2) · 1-palmitoyl-2-linoleoyl-3-acetyl-rac glycerol (1) · Analgesics (1) · Blood Specimen Collection (1) · Capecitabine (1) · Carboplatin (1)
BeyondSpring Pharmaceuticals Inc. (4) · Enzychem Lifesciences Corporation (3) · Jiangsu T-Mab Biopharma Co.,Ltd (3) · Tianjin SinoBiotech Ltd. (3) · Anhui Provincial Hospital (2) · Biocad (2) · Insel Gruppe AG, University Hospital Bern (2) · Lei Li (2) · Sandoz (2) · Teva Branded Pharmaceutical Products R&D, Inc. (2) · Ankara Etlik City Hospital (1) · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. (1) · Cinnagen (1) · Copenhagen University Hospital, Rigshospitalet (1) · Dartmouth-Hitchcock Medical Center (1)
China (18) · Russia (8) · Ukraine (7) · United States (7) · France (3) · India (3) · Romania (3) · Spain (3) · Switzerland (3) · Denmark (2) · Germany (2) · Poland (2) · South Korea (2) · Argentina (1) · Brazil (1)
Binghe XU, MD (2) · Christa Koenig, MD (2) · Min-Soo Park, Professor (2) · Alexander Pecheny, PhD (1) · Anderson B Collier, MD (1) · Andrei Horinko, MD (1) · Andrei Rusin, MD,PhD (1) · Andrei Sinykov, PhD (1) · Arash Jenabian, Professor (1) · Binhe Xu, MD (1) · Bogdan Kotiv, MD, PhD (1) · Byakhov Michael, MD, PhD (1)
PMID 33789616, PMID 28637287, PMID 24485296, PMID 27020170, PMID 30755109, PMID 31724334, PMID 32970104, PMID 33655413, PMID 35084480, PMID 35792924, PMID 35943786, PMID 38400942, PMID 39696092
2015 (1)